Dulaglutide vs Semaglutide

Dulaglutide (brand name Trulicity) and semaglutide (brand names Ozempic, Wegovy, Rybelsus) are both GLP-1 receptor agonists, a type of medication that helps control blood sugar and reduce cardiovascular risk. Dulaglutide is approved for type 2 diabetes and cardiovascular risk reduction, while semaglutide is also approved for obesity and chronic kidney disease. Dulaglutide is given as a weekly injection, whereas semaglutide comes in multiple forms: a weekly injection (Ozempic, Wegovy) or a daily pill (Rybelsus). Both are made by different drug companies.

AI summary of the sources below.